MAXY VII (Factor VIIa): Issued Patents and Published Applications Owned by Maxygen or Exclusively Licensed to Maxygen

US Patent #: 6,017,882
Title: Modified Vitamin K-Dependent Polypeptides

US Patent #: 6,693,075
Title: Modified Vitamin K-Dependent Polypeptides

US Patent #: 6,806,063
Title: Factor VII or VIIa-Like Molecules

Published PCT Application #: WO 99/20767
Title: Modified Vitamin K-Dependent Polypeptides

Published PCT Application #: WO 00/66753
Title: Modified Vitamin K-Dependent Polypeptides

Published PCT Application #: WO 01/58935
Title: Factor VII or VIIa-Like Molecules

Published PCT Application #: WO 03/093465
Title: Factor VII or VIIa Polypeptide Variants

Published PCT Application #: WO 2004/029091
Title: FVII or FVIIa Variants Having Increased Clotting Activity

Published PCT Application #: WO 2004/083361
Title: FVII or FVIIa Variants

Published PCT Application #: WO 2004/111242
Title: Factor VII or VIIa GLA Domain Variants

Published PCT Application #: WO 2005/023308
Title: Formulations of Vitamin K-Dependent Polypeptides and Sulfoalkyl Ether Cycloextrins

Published PCT Application #: WO 2006/074664
Title: Method for Purification of Factor VII

Published PCT Application #: WO 2006/114105
Title: Methods for Treating Bleeding

Published PCT Application #: WO 2007/013993
Title: In-Solution Activation of Factor VII

 Maxygen has provided the patents as PDF files.

Return to Science & Technology